Can’t find what you’re looking for? Just contact us and we’ll get back to you.
Empower your organization with a suite of forecasting tools designed to enhance decision-making and refine your commercial strategy.
Discover >
Streamline your business development and licensing strategies with actionable insights and informed decision making, supported by gold-standard data.
Enhance asset management with powerful tools that enable data-driven decisions and optimize your portfolio strategy for sustainable growth.
Stay ahead of the competition by leveraging competitive intelligence solutions to monitor market trends, anticipate competitor actions, and make strategic data-driven decisions.
Build stronger valuation narratives for biotech M&A, IPOs, capital raising and strategic advisory. Use Evaluate to assess market potential, benchmark forecasts, monitor catalysts and support client recommendations with evidence-backed insight.
Build stronger valuation narratives for biotech M&A, IPOs, capital raising and strategic advisory. Use Evaluate Pharma to assess market potential, benchmark forecasts, monitor catalysts and support client recommendations with evidence-backed insight.
Assess pharma and biotech targets, pressure-test commercial assumptions and evaluate the market case behind potential investments. Evaluate supports commercial diligence, investment committee materials and portfolio value creation.
Track catalysts, forecast revisions, regulatory events and competitive changes that could affect pharma and biotech company valuations. Evaluate to supports investment research, position monitoring and event-driven analysis.
Case Study
